Search for: "Novartis Ag"
Results 261 - 280
of 440
Sort by Relevance
|
Sort by Date
29 Jun 2011, 3:34 am
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
15 Jun 2011, 4:56 am
(updated) (IP Whiteboard) Canada: Study debunks Chamber of Commerce claims on Canadian patent law (Michael Geist) EU: Opinion of the AG for C-125/10 is out! [read post]
18 May 2011, 1:11 pm
Nearly all over-the-counter manufacturers already include a dosing table with both weight and age. [read post]
18 May 2011, 12:33 am
General New texts in play in WIPO traditional knowledge, genetic resources talks (IP Watch) World Health Assembly to address organisational reform, IP issues (IP Watch) Australia: Therapeutic Goods Legislation Amendment (Copyright) Bill 2011 passed unamended (IP Whiteboard) EU: AG Bot says, it’s not the re-boxer who matters but the boss: C? [read post]
29 Apr 2011, 7:43 am
Novartis Corp. [read post]
19 Apr 2011, 5:04 pm
Infosint (IPKat) (PatLit) Clobex (Clobetasol) – US: Galderma, Dermalogix agree to end Clobex suit with Paddock (Patent Docs) Crestor (Rosuvastatin) – US: Palmetto files patent infringement suit against AstraZeneca based on its Crestor product; AstraZeneca files for declaratory judgment of non-infringement and invalidity (Patent Docs) Drospirenone, Ethinylestradiol – UK: Shedding further light on obviousness: Gedeon Richter PC v Bayer Schering Pharma AG (Kluwer Patent Blog)… [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
11 Apr 2011, 8:53 pm
Novartis AG v. [read post]
11 Apr 2011, 12:04 pm
Risk factors include advanced age, concomitant nephrotoxic medicinal products, concomitant diuretic therapy or dehydration occurring after ACLASTA administration. [read post]
6 Apr 2011, 12:18 am
Chiron Healthcare & Novartis (EPLAW) India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
1 Apr 2011, 8:54 pm
For example, the multinational pharmaceutical company Novartis AG entered into an access agreement with the Brazilian Association for the Sustainable Use of the Biodiversity of Amazonia ("BIOAMAZONIA") under whose terms BIOAMAZONIA received an upfront payment of $4,000,000 in return for supplying Novartis with 30,000 promising biological samples over a three-year period; furthermore, should any of these samples lead to a drug that receives… [read post]
30 Mar 2011, 12:56 pm
Bayer AG's US healthcare arm faces a gender discrimination lawsuit that could leave the company with $100 million in employee pay outs. [read post]
29 Mar 2011, 9:19 pm
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
26 Mar 2011, 10:17 am
Similar lawsuits have been filed recently against other major companies: Publicis Group S.A., the U.S. business and French advertising company for Toshiba Corp.; Goldman Sachs Group Inc.; and the U.S. unit of Novartis AG. [read post]
23 Mar 2011, 1:30 pm
The drug is jointly developed by Genentech Inc., a member of the Roche group, under an agreement with Novartis Pharma AG. [read post]
21 Mar 2011, 12:44 pm
In July, Novartis AG’s U.S. unit agreed to pay $175 million to settle a long-running discrimination brought by Sanford Wittels. [read post]
16 Mar 2011, 3:50 am
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
4 Mar 2011, 5:55 am
This case has to ability to gut summary judgment in any discrimination case (except age) in which a supervisor is accused of having a discriminatory animus. [read post]
27 Feb 2011, 1:35 pm
For example, Toshiba Corp was sued in January for $100 million, and last July, Novartis AG agreed to pay $175 million to settle a class-action lawsuit accusing it of discriminating against 5,600 women sales representatives. [read post]
